Common daily pill slashes colorectal cancer’s return by 55% | A study involving more than 1,000 cancer patients has found that a low dose of aspirin halves the risk of colorectal tumors returning after surgery.
Immunotherapy trial helps cancer patients with tumours live 40% longer
